Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Disease Surveillance01:26

Principles of Disease Surveillance

542
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
542
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

8.7K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.7K
Lung Capacity01:47

Lung Capacity

56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Inhaled Medications01:23

Inhaled Medications

795
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
795
Stages of Infection01:26

Stages of Infection

65.2K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.2K
Stages of General Anesthesia01:22

Stages of General Anesthesia

1.7K
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer.

Cancer·2026
Same author

High-Risk Head and Neck Cutaneous Squamous Cell Carcinoma Treated with Mohs Micrographic Surgery: Low Actuarial Recurrence Rates Unless Multiple Major Risk Factors Present.

Journal of the American Academy of Dermatology·2026
Same author

Optimization of Pathologists' Roles in Molecular Biomarker Testing in Metastatic Breast Cancer: A Consensus Statement.

The Journal of molecular diagnostics : JMD·2026
Same author

Executive Summary of the American Radium Society Appropriate Use Criteria for Selective Use of Pelvic Radiation Therapy in Locally Advanced Rectal Cancer: A Consensus Statement.

International journal of radiation oncology, biology, physics·2026
Same author

Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma.

American journal of clinical oncology·2026
Same author

Radiation Therapy for Gastric Cancer: An ASTRO Clinical Practice Guideline.

Practical radiation oncology·2025

Related Experiment Video

Updated: Jan 30, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

845

Active Surveillance for Medically Inoperable Stage IA Lung Cancer in the Elderly.

Hyunsoo J No1, Nataniel H Lester-Coll2, David J Seward3

  • 1Radiation Oncology, Larner College of Medicine at the University of Vermont, Burlington, USA.

Cureus
|January 17, 2019
PubMed
Summary

Active surveillance (AS) is a safe option for elderly patients with early-stage lung cancer and co-morbidities. This approach avoids aggressive treatment, with no cancer-related deaths observed in the study group.

Keywords:
active surveillanceelderlynon-small cell lung cancer

More Related Videos

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.8K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

411

Related Experiment Videos

Last Updated: Jan 30, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

845
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.8K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

411

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Thoracic Surgery

Background:

  • Standard treatment for stage IA lung cancer may be overly aggressive for elderly patients with significant co-morbidities.
  • Active surveillance (AS) offers a less invasive alternative, reserving radiation therapy (RT) for documented disease progression.

Purpose of the Study:

  • To evaluate the outcomes of active surveillance (AS) in elderly, medically inoperable patients with stage IA lung cancer.
  • To identify factors predicting indolent disease progression in this patient cohort.

Main Methods:

  • Retrospective review of 12 patients (≥70 years) with stage IA lung cancer and co-morbidities managed with AS.
  • Data collected included Charlson-Deyo Comorbidity Index (CDCI), histology, tumor size changes, and volume doubling time (VDT).
  • Radiation therapy (RT) was reserved for clear disease progression.

Main Results:

  • Median patient age was 78; all had CDCI ≥1, and 7 had CDCI ≥2. Adenocarcinoma was the most common histology (47%).
  • Median freedom-from-RT was 21.4 months. Median VDT was significantly longer for untreated nodules (1153 days) vs. treated (189 days).
  • No regional or distant progression occurred, and no cancer-related deaths were reported. Two deaths were due to cardiovascular events.

Conclusions:

  • Active surveillance (AS) appears to be a safe and effective strategy for selected elderly patients with stage IA lung cancer and co-morbidities.
  • This approach avoids potentially detrimental aggressive treatments, with favorable outcomes observed in the study.
  • Further prospective studies are warranted to confirm these findings and refine AS protocols.